🇺🇸 FDA
Patent

US 10369145

Coumarin derivatives and methods of use in treating hyperproliferative diseases

granted A61KA61K31/422A61K31/427

Quick answer

US patent 10369145 (Coumarin derivatives and methods of use in treating hyperproliferative diseases) held by DISCOVERYBIOMED, INC. expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DISCOVERYBIOMED, INC.
Grant date
Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/422, A61K31/427, A61K31/4439, A61K31/4709